Imis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 11-12-2024
- Paid Up Capital ₹ 3.00 M
as on 11-12-2024
- Company Age 43 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.76 Cr
as on 11-12-2024
- Satisfied Charges ₹ 1.13 Cr
as on 11-12-2024
- Revenue 36.11%
(FY 2022)
- Profit -20.75%
(FY 2022)
- Ebitda 110.23%
(FY 2022)
- Net Worth 7.47%
(FY 2022)
- Total Assets 45.22%
(FY 2022)
About Imis Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹2.76 Cr. The company has closed loans amounting to ₹1.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dubagunta Indumathi, Naga Vepakomma, Nagamallika Gudipaty, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239AP1981PTC003079
- Company No.
003079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- LocationNa, Andhra Pradesh
- Telephone
- Email Address
- Website
- Social Media
What products or services does Imis Pharmaceuticals Pvt Ltd offer?
Imis Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Ayurvedic Cosmetics, Ayurvedic Hair Oil, Ayurvedic Medicine, Asthma Herbal Capsule & Tablet, Ayurvedic Menstrual Cycle Medicine, Ayurvedic, Herbal Oils and Cosmetics, Ayurvedic,Herbal Products & Medicine, Herbal & Ayurvedic Medical Services, Ayurvedic Treatment, Anti Allergic Drug.
Who are the key members and board of directors at Imis Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naga Vepakomma  | Managing Director | 01-Apr-1998 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagaprasuna Balantrapu | Director | 04-Aug-2017 | Current |
| Dubagunta Indumathi | Director | 25-Jun-1981 | Current |
| Nagamallika Gudipaty | Director | 12-Jun-2015 | Current |
| Dubagunta Nagasaila | Director | 12-Jun-2015 | Current |
Financial Performance of Imis Pharmaceuticals.
Imis Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 36.11% increase. The company also saw a substantial fall in profitability, with a 20.75% decrease in profit. The company's net worth moved up by a moderate rise of 7.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imis Pharmaceuticals?
Unlock access to Imis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Barefoot Change Associates Private LimitedActive 5 months 9 daysDubagunta Nagasaila is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 15 May 2009 | ₹2.76 Cr | Open |
Andhra Bank Creation Date: 15 Dec 2008 | ₹3.00 M | Satisfied |
Andhra Bank Creation Date: 20 Jan 2005 | ₹0.65 M | Satisfied |
How Many Employees Work at Imis Pharmaceuticals?
Imis Pharmaceuticals has a workforce of 158 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
